Popular Trials
Bisphosphonate
Zoledronic Acid for Parkinson's Disease
Recruiting2 awardsPhase 4
Scottsdale, Arizona
This trial is testing whether a single infusion of zoledronic acid can help prevent fractures in people with Parkinson's disease or parkinsonism. A total of 3500 participants will be enrolled in the United States.
Dietary Supplement
SCF Supplementation for Bone Health in Adolescents
Recruiting0 awardsPhase 2
Miami, Florida
This trial will study the effects of soluble corn fiber (SCF) supplementation on bone metabolism in growing adolescents compared to controls, by administering SCF or a placebo to adolescents aged 10-13 years, and assessing bone mass, bone related biomarkers, and the fecal microbiome at baseline and after 12 months.
Educational Interventions for Osteoporosis
Recruiting1 award6 criteria
Quebec
This trial will focus on improving evidence-based osteoporosis diagnosis and treatment for women 50 and older who have suffered a fragility fracture. It will compare the current situation to an optimal one and propose interventions to improve care. The effectiveness of these interventions will be evaluated using a randomized control design.
Monoclonal Antibodies
Romosozumab for Osteoporosis in Multiple Myeloma
Recruiting1 awardPhase 1
Basking Ridge, New Jersey
This trial is testing romosozumab, a medication that helps build and strengthen bones, in postmenopausal people with multiple myeloma. These patients often have weak bones due to osteoporosis and bone disease related to their condition. Romosozumab works by promoting new bone growth and preventing bone loss. Romosozumab is a recently approved monoclonal antibody that promotes bone formation and prevents bone resorption.
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Romosozumab for Anorexia Nervosa
Recruiting1 awardPhase 3
Boston, Massachusetts
This trial tests if romosozumab can help women with anorexia nervosa build stronger bones over a year, followed by alendronate to maintain the strength. The goal is to see if this combination improves bone health. Romosozumab is a treatment that both increases bone formation and decreases bone breakdown, primarily used to reduce fracture risk in postmenopausal women with osteoporosis.
Radiation
IGIMRT Dosing Schedules for Cancer Spread to Bone/Spine
Recruiting2 awardsPhase 3
San Francisco, California
This trial is studying two ways of giving high-dose radiation for treatment of cancer that has spread to bone, the spine, soft tissue, or lymph nodes. One way is 27 Gy in three fractions (3 days) and the other is 24 Gy in one fraction (1 day).
Potassium Citrate for Kidney Disease
Recruiting0 awardsPhase 2 & 3
Bronx, New York
This trial tests if potassium citrate can improve bone health in adults & kids with kidney disease. Participants will provide blood & urine samples, answer health/diet questions & take either potassium citrate or placebo for 6 months. Results from bone imaging will be compared.
Trials With No Placebo
Behavioral Intervention
PREVENT Program for Hip Fractures
Recruiting1 award3 criteria
Hamilton, Ontario
This trial is studying a program called PREVENT that was designed to prevent hip fractures in older adults living in long-term care homes. Hip fractures are common in this population and can lead to hospitalization,
Device
AGN1 LOEP for Preventing Secondary Hip Fractures
Recruiting1 award3 criteria
Saint John's, Newfoundland and Labrador
This trial aims to test a new drug, AGN1, to see if it can prevent second hip fractures in women with osteoporosis who are already being treated for their first hip fracture. Around
Diagnostic Test
CT-Based Bone Assessment for Fracture Risk in COPD
Recruiting1 award4 criteria
Iowa City, Iowa
This trial is testing a new tool to assess osteoporosis and bone loss in COPD patients, which may be more accurate than existing methods. The study will look at how different factors related to COPD impact bone structure and the risk of fractures.
Bone Property Testing for Fracture Risk
Recruiting1 award3 criteria
Boston, Massachusetts
This trial is testing a new way to measure if someone is at risk for breaking a hip or radius. They think that women who have already fractured these bones have different bone properties than those who haven't, and that this new method can identify these differences.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.